Shares of genetic testing company Myriad Genetics (NASDAQ:MYGN) jumped 3.7% in the afternoon session after the company signed an exclusive agreement with Zydus Lifesciences to commercialize a trio of ...
Stocks finished firmly ahead on a high-volume day Tuesday as the Trump administration hinted that a trade deal with one nation is done. The news comes as Amazon.com retreated slightly amid a dispute ...